Disul ram in glioma: literature review of drug repurposing

HIGHLIGHTS

• who: August et al. from the Indiana University Bloomington have published the paper: Disul ram in glioma: Literature review of drug repurposing, in the Journal: (JOURNAL)
• what: Malignant gliomas have a poor prognosis and high recurrence rate, posing a major threat to global public health.
• how: This review describes the drug repurposing of DSF in gliomas. The results showed that a maximum dose of 500 mg/day of DSF was well tolerated with or without combined Cu while 1000 mg/day was poorly tolerated. The results showed that 14% of the patients achieved . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.